$PRNB announced last week, late-breaker research session at the American Academy of Dermatology (AAD) coming up on June 12-14. Full data set presentation from the Phase 2 Part B pemphigus trial with its investigational drug rilzabrutinib. aad.org/member/meetings-edu...
  • 1
1 Like